Learning Objectives:

By the end of this session, the participant will be able to…

1. Recognize nanotechnology’s potential implications in rheumatology

2. Understand the role of novel platforms of drug delivery in the treatment of rheumatoid arthritis


The Speaker is a consultant for: Salix Pharmaceuticals, Thermo Fisher Scientific, and Novartis

Speaker Name: 
Terri Tarrant, MD; Associate Professor of Medicine at UNC Chapel Hill
Duke South 3rd Floor Conference Room (purple zone)
200 Trent Drive
Durham, NC 27710
United States
Room Number: 
Session date: 
Tuesday, May 3, 2016 - 8:00am to 9:00am
  • 1.00 AMA PRA Category 1 Credit(s)

Please login or register to take this course.